imbb logo for mobile
 

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity

Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity

IMBB Researchers in collaboration with colleagues from Univ. of Geneva, Univ. of Crete and BRFAA discovered and validated distinct gene signatures conferring susceptibility and predicting the severity of Systemic Lupus Erythematosus. This landmark study identifies novel targets for personalized care.

[Pubmed]